These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10494879)

  • 21. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
    Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
    J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitors of ser/thr phosphatases 1 and 2A induce apoptosis in pituitary GH3 cells.
    Tergau F; Weichert J; Quentin I; Opitz R; von Zezschwitz C; Marwitz J; Ritz V; Steinfelder HJ
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):8-16. PubMed ID: 9228184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.
    Ludescher C; Hilbe W; Eisterer W; Preuss E; Huber C; Gotwald M; Hofmann J; Thaler J
    J Natl Cancer Inst; 1993 Nov; 85(21):1751-8. PubMed ID: 8105101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel MDR1 GT1292-3TG (Cys431Leu) genetic variation and its effect on P-glycoprotein biologic functions.
    Crouthamel MH; Wu D; Yang Z; Ho RJ
    AAPS J; 2010 Dec; 12(4):548-55. PubMed ID: 20623213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of multidrug-resistant pituitary tumor cells.
    Nelson EJ; Hinkle PM
    Endocrinology; 1992 Jun; 130(6):3246-56. PubMed ID: 1350759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation between MDR1 mRNA levels, resistance factor, and the efficiency of P-glycoprotein-mediated efflux of pirarubicin in multidrug-resistant K562 sublines.
    Meesungnoen J; Jay-Gerin JP; Mankhetkorn S
    Can J Physiol Pharmacol; 2002 Nov; 80(11):1054-63. PubMed ID: 12489924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of P-glycoprotein and mdr1b mRNA expression by growth factors in primary rat hepatocyte culture.
    Hirsch-Ernst KI; Ziemann C; Schmitz-Salue C; Foth H; Kahl GF
    Biochem Biophys Res Commun; 1995 Oct; 215(1):179-85. PubMed ID: 7575588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein.
    Quesada AR; García Grávalos MD; Fernández Puentes JL
    Br J Cancer; 1996 Sep; 74(5):677-82. PubMed ID: 8795567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Constitutive expression of functional P-glycoprotein in rat hepatoma cells.
    Fardel O; Loyer P; Lecureur V; Glaise D; Guillouzo A
    Eur J Biochem; 1994 Jan; 219(1-2):521-8. PubMed ID: 7905826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells.
    Sharom FJ; Yu X; Lu P; Liu R; Chu JW; Szabó K; Müller M; Hose CD; Monks A; Váradi A; Seprôdi J; Sarkadi B
    Biochem Pharmacol; 1999 Aug; 58(4):571-86. PubMed ID: 10413294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
    Beketic-Oreskovic L; Durán GE; Chen KG; Dumontet C; Sikic BI
    J Natl Cancer Inst; 1995 Nov; 87(21):1593-602. PubMed ID: 7563202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic transfer of non-P-glycoprotein-mediated multidrug resistance (MDR) in somatic cell fusion: dissection of a compound MDR phenotype.
    Eijdems EW; Borst P; Jongsma AP; de Jong S; de Vries EG; van Groenigen M; Versantvoort CH; Nieuwint AW; Baas F
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3498-502. PubMed ID: 1348862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Function and expression of ATP-binding cassette transporters in cultured human Y79 retinoblastoma cells.
    Ishikawa Y; Nagai J; Okada Y; Sato K; Yumoto R; Takano M
    Biol Pharm Bull; 2010; 33(3):504-11. PubMed ID: 20190417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S9788 modulation of P-glycoprotein- and Multidrug-related protein-mediated multidrug resistance by Servier 9788 in doxorubicin-resistant MCF7 cells.
    Bichat F; Solis-Recendez G; Poullain MG; Poupon MF; Khayat D; Bastian G
    Biochem Pharmacol; 1998 Aug; 56(4):497-502. PubMed ID: 9763226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by AV200, a new ardeemin derivative.
    Méndez-Vidal C; Quesada AR
    Cancer Lett; 1998 Oct; 132(1-2):45-50. PubMed ID: 10397452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between functional and molecular analysis of mdr1 P-glycoprotein in human solid-tumor xenografts.
    Broxterman HJ; Feller N; Kuiper CM; Boven E; Versantvoort CH; Teerlink T; Pinedo HM; Lankelma J
    Int J Cancer; 1995 Jun; 61(6):880-6. PubMed ID: 7790125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
    Abe T; Koike K; Ohga T; Kubo T; Wada M; Kohno K; Mori T; Hidaka K; Kuwano M
    Br J Cancer; 1995 Aug; 72(2):418-23. PubMed ID: 7640227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C; Guan X; Xue H; Wang P; Wang M; Gai X
    Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.
    Chao CC
    FEBS Lett; 1995 Oct; 373(3):285-90. PubMed ID: 7589484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.